US6828415B2
(en)
*
|
1993-02-19 |
2004-12-07 |
Zentaris Gmbh |
Oligopeptide lyophilisate, their preparation and use
|
US20040067157A1
(en)
*
|
1993-07-22 |
2004-04-08 |
Clearant, Inc. |
Methods for sterilizing biological materials
|
US5362442A
(en)
*
|
1993-07-22 |
1994-11-08 |
2920913 Canada Inc. |
Method for sterilizing products with gamma radiation
|
EP0788799A3
(fr)
*
|
1996-02-07 |
1998-10-21 |
ASTA Medica Aktiengesellschaft |
Antagonistes de LHRH pour le traitement des désordres de la fertilité
|
US5945128A
(en)
*
|
1996-09-04 |
1999-08-31 |
Romano Deghenghi |
Process to manufacture implants containing bioactive peptides
|
US20020111603A1
(en)
|
1996-12-02 |
2002-08-15 |
Societe De Conseils De Recherches Et D'application |
Device for local administration of solid or semi-solid formulations and delayed-release formulations for proposal parental administration and preparation process
|
IT1304152B1
(it)
*
|
1998-12-10 |
2001-03-08 |
Mediolanum Farmaceutici Srl |
Composizioni comprendenti un peptide ed acido polilattico-glicolicoatte alla preparazione di impianti sottocutanei aventi un prolungato
|
US8173592B1
(en)
*
|
1999-03-31 |
2012-05-08 |
Zentaris Ivf Gmbh |
Method for a programmed controlled ovarian stimulation protocol
|
ATE244558T1
(de)
*
|
1999-04-16 |
2003-07-15 |
Novo Nordisk As |
Trockene formbare arzneistoffformulierung
|
TWI284048B
(en)
*
|
2000-01-27 |
2007-07-21 |
Zentaris Ag |
Compressed microparticles for dry injection
|
US20040086420A1
(en)
*
|
2000-03-23 |
2004-05-06 |
Macphee Martin J. |
Methods for sterilizing serum or plasma
|
EP1313425B1
(fr)
*
|
2000-07-14 |
2007-03-07 |
Novo Nordisk A/S |
Procede pour mouler une composition pharmaceutique dans un materiau d'emballage
|
US6362308B1
(en)
|
2000-08-10 |
2002-03-26 |
Alkermes Controlled Therapeutics Inc. Ii |
Acid end group poly(d,l-lactide-co-glycolide) copolymers high glycolide content
|
KR100876538B1
(ko)
*
|
2000-08-17 |
2008-12-31 |
아에테르나 젠타리스 게엠베하 |
Lhrh 길항제의 염의 제조방법
|
US7635592B2
(en)
*
|
2000-08-21 |
2009-12-22 |
Rice University |
Tissue engineering scaffolds promoting matrix protein production
|
US6682695B2
(en)
*
|
2001-03-23 |
2004-01-27 |
Clearant, Inc. |
Methods for sterilizing biological materials by multiple rates
|
DE50210646D1
(de)
*
|
2001-05-23 |
2007-09-20 |
Hexal Ag |
Verfahren zur herstellung von implantaten mittels lösungsmittelfreier herstellung eines homogenisats
|
US6696060B2
(en)
*
|
2001-06-14 |
2004-02-24 |
Clearant, Inc. |
Methods for sterilizing preparations of monoclonal immunoglobulins
|
EP1408876A4
(fr)
|
2001-06-22 |
2004-09-22 |
Durect Corp |
Implants coaxiaux a liberation prolongee d'ordre 0
|
US20030031584A1
(en)
*
|
2001-08-10 |
2003-02-13 |
Wilson Burgess |
Methods for sterilizing biological materials using dipeptide stabilizers
|
US6946098B2
(en)
|
2001-08-10 |
2005-09-20 |
Clearant, Inc. |
Methods for sterilizing biological materials
|
US7252799B2
(en)
*
|
2001-08-31 |
2007-08-07 |
Clearant, Inc. |
Methods for sterilizing preparations containing albumin
|
US6749851B2
(en)
|
2001-08-31 |
2004-06-15 |
Clearant, Inc. |
Methods for sterilizing preparations of digestive enzymes
|
GB0122113D0
(en)
*
|
2001-09-11 |
2001-10-31 |
Astrazeneca Ab |
Composition
|
US20030095890A1
(en)
*
|
2001-09-24 |
2003-05-22 |
Shirley Miekka |
Methods for sterilizing biological materials containing non-aqueous solvents
|
US6783968B2
(en)
|
2001-09-24 |
2004-08-31 |
Clearant, Inc. |
Methods for sterilizing preparations of glycosidases
|
US20030185702A1
(en)
*
|
2002-02-01 |
2003-10-02 |
Wilson Burgess |
Methods for sterilizing tissue
|
US8454997B2
(en)
|
2001-12-18 |
2013-06-04 |
Novo Nordisk A/S |
Solid dose micro implant
|
US20030124023A1
(en)
*
|
2001-12-21 |
2003-07-03 |
Wilson Burgess |
Method of sterilizing heart valves
|
WO2003097237A2
(fr)
*
|
2002-05-13 |
2003-11-27 |
Becton, Dickinson, And Company |
Systeme de prelevement d'echantillon comprenant un inhibiteur de protease
|
US6908591B2
(en)
*
|
2002-07-18 |
2005-06-21 |
Clearant, Inc. |
Methods for sterilizing biological materials by irradiation over a temperature gradient
|
US20040013562A1
(en)
*
|
2002-07-18 |
2004-01-22 |
Wilson Burgess |
Methods for sterilizing milk.
|
WO2004032750A1
(fr)
*
|
2002-10-10 |
2004-04-22 |
Becton Dickinson And Company |
Systeme collecteur d'echantillons avec inhibiteur de caspase
|
JP5591434B2
(ja)
|
2002-12-20 |
2014-09-17 |
ゼリス ファーマシューティカルズ インコーポレイテッド |
皮内注射方法
|
GB0304726D0
(en)
*
|
2003-03-01 |
2003-04-02 |
Ardana Bioscience Ltd |
New Process
|
US9445901B2
(en)
*
|
2003-03-12 |
2016-09-20 |
Deger C. Tunc |
Prosthesis with sustained release analgesic
|
US7833545B2
(en)
|
2003-04-29 |
2010-11-16 |
The General Hospital Corporation |
Methods and devices for the sustained release of multiple drugs
|
US20040224000A1
(en)
*
|
2003-05-05 |
2004-11-11 |
Romano Deghenghi |
Implants for non-radioactive brachytherapy of hormonal-insensitive cancers
|
US20050124965A1
(en)
*
|
2003-12-08 |
2005-06-09 |
Becton, Dickinson And Company |
Phosphatase inhibitor sample collection system
|
US7114074B2
(en)
*
|
2003-12-22 |
2006-09-26 |
Graphic Security Systems Corporation |
Method and system for controlling encoded image production using image signatures
|
AU2004313245B2
(en)
*
|
2003-12-30 |
2011-04-14 |
Durect Corporation |
Polymeric implants, preferably containing a mixture of PEG and PLG, for controlled release of active agents, preferably a GNRH
|
FR2865938B1
(fr)
*
|
2004-02-05 |
2006-06-02 |
Sod Conseils Rech Applic |
Formulation retard solide comprenant de l'acetate de triptoreline
|
US20050244478A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Anti-excititoxic sustained release intraocular implants and related methods
|
EP1773293B1
(fr)
*
|
2004-06-17 |
2015-04-15 |
Endo Pharmaceuticals Solutions Inc. |
Compositions et methodes de traitement de la puberte centrale precoce
|
CA2575988C
(fr)
|
2004-08-04 |
2014-02-18 |
Brookwood Pharmaceuticals, Inc. |
Procede de production de systemes d'administration, et systemes d'administration
|
EP1817056B1
(fr)
|
2004-11-11 |
2014-08-13 |
The General Hospital Corporation |
Activation du recepteur a l'hormone parathyroide et expansion des cellules souches et progenitrices
|
DK1941798T3
(da)
|
2004-12-17 |
2012-08-27 |
Devgen Nv |
Nematicide præparater
|
EP1835885A1
(fr)
*
|
2004-12-23 |
2007-09-26 |
Durect Corporation |
IMPLANTS POLYMÉRIQUES, CONTENANT DE PRÉFÉRENCE UN MÉLANGE DE PEG ET DE PLG, POUR UNE LIBÉRATION CONTRÔLÉE D'UNE GnRH
|
EP2457564A1
(fr)
*
|
2005-03-11 |
2012-05-30 |
Endo Pharmaceuticals Solutions Inc. |
Preparation d'octreotide a liberation lente
|
US7759312B2
(en)
*
|
2005-03-11 |
2010-07-20 |
Endo Pharmaceuticals Solutions Inc. |
Delivery of dry formulations of octreotide
|
US7942867B2
(en)
*
|
2005-11-09 |
2011-05-17 |
The Invention Science Fund I, Llc |
Remotely controlled substance delivery device
|
EP1837014A1
(fr)
*
|
2006-03-21 |
2007-09-26 |
Hexal Ag |
Implants sous-cutanés contenant un polymère de polylactide résistant à la dégradation et un analogue de la LH-RH
|
US8206827B2
(en)
*
|
2007-03-15 |
2012-06-26 |
Nanovere Technologies, Llc |
Dendritic polyurethane coating
|
MX2009011641A
(es)
*
|
2007-04-27 |
2010-03-04 |
Endo Pharmaceuticals Solutions |
Agentes de liberacion para dispositivo de implante y metodos para utilizar los mismos.
|
UA99830C2
(uk)
*
|
2007-06-06 |
2012-10-10 |
Дебио Ресшерчи Фармасютикю С.А. |
Фармацевтична композиція з пролонгованим вивільненням, виготовлена з мікрочастинок
|
US20090035351A1
(en)
*
|
2007-07-20 |
2009-02-05 |
Medtronic Vascular, Inc. |
Bioabsorbable Hypotubes for Intravascular Drug Delivery
|
US8728528B2
(en)
|
2007-12-20 |
2014-05-20 |
Evonik Corporation |
Process for preparing microparticles having a low residual solvent volume
|
GB0810990D0
(en)
*
|
2008-06-16 |
2008-07-23 |
Q Chip Ltd |
Device and method of making solid beads
|
WO2009158415A1
(fr)
*
|
2008-06-25 |
2009-12-30 |
Endo Pharmaceuticals Solutions Inc. |
Implant d'octréotide comportant un agent de libération
|
JP5622725B2
(ja)
|
2008-06-25 |
2014-11-12 |
エンド ファーマスーティカルズ ソリューションズ インコーポレイテッド.Endo Pharmaceuticals Solutionsinc. |
エキセナチド及び他のポリペプチド類の持続的送達
|
EP2246063A1
(fr)
*
|
2009-04-29 |
2010-11-03 |
Ipsen Pharma S.A.S. |
Formulations à libération prolongée contenant des analogues de GnRH
|
US8604101B2
(en)
|
2010-03-24 |
2013-12-10 |
Basf Se |
Process for producing aqueous dispersions of thermoplastic polyesters
|
KR20130039729A
(ko)
|
2010-03-24 |
2013-04-22 |
바스프 에스이 |
열가소성 폴리에스테르의 수성 분산액의 제조 방법
|
US20120046225A1
(en)
|
2010-07-19 |
2012-02-23 |
The Regents Of The University Of Colorado, A Body Corporate |
Stable glucagon formulations for the treatment of hypoglycemia
|
AU2012225268B2
(en)
|
2011-03-10 |
2016-10-20 |
Xeris Pharmaceuticals, Inc. |
Stable formulations for parenteral injection of peptide drugs
|
WO2013041649A1
(fr)
|
2011-09-23 |
2013-03-28 |
Basf Se |
Utilisation d'une dispersion aqueuse de polyesters biodégradables
|
DE102011114864A1
(de)
|
2011-10-05 |
2013-04-11 |
Acino Ag |
Verfahren zur Herstellung einer homogenen Pulvermischung und Verfahren zur Herstellung eines Implantats sowie Implantat
|
US9138479B2
(en)
|
2011-10-31 |
2015-09-22 |
Xeris Pharmaceuticals, Inc. |
Formulations for the treatment of diabetes
|
IN2014DN09621A
(fr)
*
|
2012-05-14 |
2015-07-31 |
Teijin Ltd |
|
US9125805B2
(en)
|
2012-06-27 |
2015-09-08 |
Xeris Pharmaceuticals, Inc. |
Stable formulations for parenteral injection of small molecule drugs
|
DE102013011399A1
(de)
|
2012-07-31 |
2014-02-06 |
Amw Gmbh |
Implantat mit Risperidon
|
US9018162B2
(en)
|
2013-02-06 |
2015-04-28 |
Xeris Pharmaceuticals, Inc. |
Methods for rapidly treating severe hypoglycemia
|
CN106413689A
(zh)
*
|
2014-04-30 |
2017-02-15 |
阿西诺供应公司 |
制备药物组合物的方法和装置
|
WO2016022831A1
(fr)
|
2014-08-06 |
2016-02-11 |
Xeris Pharmaceuticals, Inc. |
Seringues, kits et procédés pour injection intracutanée et/ou sous-cutanée de pâtes
|
US9649364B2
(en)
|
2015-09-25 |
2017-05-16 |
Xeris Pharmaceuticals, Inc. |
Methods for producing stable therapeutic formulations in aprotic polar solvents
|
US11590205B2
(en)
|
2015-09-25 |
2023-02-28 |
Xeris Pharmaceuticals, Inc. |
Methods for producing stable therapeutic glucagon formulations in aprotic polar solvents
|
AU2018275686B2
(en)
|
2017-06-02 |
2024-02-01 |
Xeris Pharmaceuticals, Inc. |
Precipitation resistant small molecule drug formulations
|